Synergy CHC Corp.

SNYR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2019 FY2018 FY2017 FY2016 FY2015
Revenue $30.4M $34.8M $42.8M $29.4M $33.8M $35.6M $34.8M $13.5M
Cost of Revenue $10.1M $11.2M $10.7M $9.1M $11.0M $9.8M $10.2M $5.3M
Gross Profit $20.3M $23.6M $32.1M $20.2M $22.8M $25.8M $24.6M $8.1M
Gross Margin 66.8% 67.9% 75.0% 68.9% 67.4% 72.4% 70.7% 60.6%
Operating Expenses
Research & Development
SG&A Expense $8.8M $4.7M $6.1M $5.5M $7.2M $8.4M $8.0M $3.4M
Operating Income $-8.5M $5.8M $10.8M $-8.0M $-4.9M $1.8M $2.9M $486.0K
Operating Margin -27.8% 16.7% 25.3% -27.1% -14.5% 5.1% 8.4% 3.6%
Interest Expense $2.0M $1.5M $1.7M $1.1M $1.0M $-1.6M $-958.7K
Pretax Income $-12.2M $2.2M $6.6M $-9.1M $-6.4M $815.6K $148.2K $-7.1M
Income Tax Expense $117.5K $102.1K $235.0K $-131.5K $247.7K $316.0K $944.4K $389.9K
Net Income $-12.3M $2.1M $6.3M $-9.2M $-6.2M $499.6K $-796.2K $-7.5M
Net Margin -40.6% 6.1% 14.8% -31.4% -18.2% 1.4% -2.3% -56.0%
EPS (Basic) $-1.27 $0.28 $0.86 $-0.10 $-0.07 $0.01 $-0.01 $-0.11
EPS (Diluted) $-1.27 $0.28 $0.86 $-0.10 $-0.07 $0.01 $-0.01 $-0.11
Shares Outstanding (Basic) 9.7M 7.6M 7.4M 89.9M 89.9M 89.2M 88.8M 81.7M
Shares Outstanding (Diluted) 9.7M 7.6M 7.4M 89.9M 89.9M 89.2M 88.8M 81.7M
Dividends Per Share
← Newer Page 1 of 2 Older →